FTC: Pharmacies Inflated Drug Prices for $7.3B Gain

The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S. Federal Trade Commission said Tuesday.